SYMON-II Clinical trials Bluejay is successfully enrolling across all participating sites in its SYMON™ II multicenter IL-6 monitoring study, with a total of 545 patients enrolled with a target of 750 ...

Context Health consumer escalation of acute deterioration response systems are now widely available to help facilitate early recognition and response to acute deterioration in hospitals. Yet, a ...

Advancing Documentation Infrastructure to Ensure Compliance with Federal HOPE Assessment Mandates and Reduce Clinician ...

Anteris Technologies Global Corp. ('Anteris” or the 'Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...

Background Congenital anomalies are among the common health problems faced by children in low- and middle-income countries, ...

DENVER, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Markets reward momentum and trends may sustain when execution follows headlines. Several companies are now moving beyond announcements and into operational ...

Trending products 2026 materialize through mastery of AI precision, supply agility, and signal orchestration in a compressed landscape. Structural forces reward execution over speculation. AI ...

LoanBud, a financial technology company modernizing access to Small Business Administration (SBA) financing, today announced the launch of its LoanBud Prequalification Platform (LoanBud.io), a ...

Tempus AI, Inc. (NASDAQ:TEM) shares are climbing today after the company unveiled a new AI-powered cancer diagnostic algorithm, building momentum ahead of its Q4 2025 earnings report scheduled for ...

Early Discover core update data shows fewer US publishers. Mueller says Google may skip sitemaps without "new and important" ...

MENLO PARK, Calif., Feb. 19, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...